Twine takes interactive approach to managing chronic conditions

As a country that spends more than $3 trillion every year on healthcare, the U.S. continues to see overall spending increase, in part because chronic diseases become more and more prevalent. Twine Health has created a methodology that helps patients control these long-lasting conditions.

Twine Health has developed software that aims to help patients improve healthy behaviors through action planning, data-informed collaboration and machine learning that allows patients to achieve their personalized health goals. With only three in 10 patients having control over their chronic conditions, Twine Health hopes to keep patients engaged in their care and collaborate with their care team.

Three months after Twine's methods for controlling blood pressure was implemented at Massachusetts General Hospital, 100 percent of patients were able to control their diseases with an average of a 26-point drop in mmHg. When implemented at Joslin Diabetes Center, patients had an average 3.2 drop in HbA1c in three months at a cost that was 40 percent less than normal.

"The key to successful healthcare and patient coaching is providing consistent human touch points both in and outside of the doctor's office," said John Moore, CEO Twine Health. "The results we've seen to date speak volumes. The Twine technology and approach enable our partners to empower patients with the tools and encouragement they need to improve their health, far better than anyone has ever done previously."

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

Trimed Popup
Trimed Popup